In preceding papers (1) it has been shown that mice and rabbits may acquire a high degree of immunity, following repeated inhalations of living pneumococci. In this work it was shown that the strain of Type I pneumococcus used produced a high mortality among the exposed rabbits and that many of the survivors have agglutinins and protective antibodies in their serum. In the present study it seemed interesting to determine the immunity response to less virulent strains. For this purpose a Type II pneumococcus was used. Pneumococcus Type II, however, is relatively avirulent for rabbits. One strain was transformed into the "R" form by repeated transfers in antipneumococcus Type II serum. The changes to the "R" form are accompanied by loss of capsule, type specificity, and virulence. This strain is referred to as Pneumococcus IIR. The stock culture of Pneumococcus Type II would cause a fatal septicemia in rabbits when injected intraperitoneally in doses of at least 0.1 cc. This strain is called Pneumococcus Type II (SAy). By repeated animal passages the virulence of this strain was raised so that an intraperitoneal injection of 0.000,01 cc. of broth culture would regularly kill rabbits. This virulent culture is designated as Pneumococcus Type II (Sv).
It has already been shown that rabbits are only susceptible to fatal infection by inhalations of virulent Type II pneumococci (Sv) (2) . Although pneumococcus septicemia may be caused in an occasional rabbit following inhalation of the slightly virulent Pneumococcus Type II, death does Irot ensue. In the present paper is reported the development of (1) agglutinins and (2) protective antibodies in the blood serum of rabbits following repeated inhalations of aviru-lent liP,, slightly virulent Type II (SAv), and virulent Type II (Sv) pneumococci.
Method
Rabbits were placed in a large spray chamber similar to that already described (3) and exposed to a spray of pneumococci. 50 cc. of an 8 hour broth culture were used for each spraying. The animals were exposed at 10 day intervals. Before each spraying, a sample of blood was obtained from the ear vein of each animal. None of the normal rabbit sera contained agglufinlus nor did the normal sera protect mice against intraperitoneal injections of 0.000,001 cc. of Type II pneumOCOCCUS.
10 days after each exposure the presence of agglutinins in the serum of exposed animals was determined by a modified thread reaction. To 1 cc. of rabbit serum diluted in normal salt solution was added 0.2 cc. of an actively growing broth culture of Pneumococcus Type II. The tubes were incubated for 2 hours in the water bath at 37°C., placed in the ice box overnight, and the reactions read the next morning. Agglutinlus were recorded as present in the serum only when the reactions were positive in a dilution of at least 1 : 10.
The presence of protective antibodies in the blood of the sprayed rabbits was determined by the ability of 0.2 cc. of serum to protect white mice against intraperitoneal injection of 0.001 cc. of Pneumococcus Type II culture, of which 0.000,001 cc. killed a normal mouse within 48 hours. The rabbit serum and culture were administered simultaneously.
Pneumococcus I I R
Of the I7 rabbits which were sprayed from 1 to 10 times with "R" forms derived from Type II pneumococcus none died from pneumococcus septicemia. Not even the 8 rabbits which were exposed l0 successive times developed any demonstrable agglutinins for Type II pneumococcus.
Neither did the sera of any of these rabbits protect mice against intraperitoneal injections of 0.001 cc. of a virulent culture of Pneumococcus Type II. As is seen from Table I the sera of these 5 animals, however, showed evidence of slight protection as demonstrated by the presence of a low degree of protective antibodies. Even the slight amount of protection afforded by these sera is not constant.
Pneumococcus Type ff (SAy)
Of 11 rabbits sprayed from 1 to 10 times with the slightly virulent Pneumococcus Type II (SAy), none died from pneumococcus septi-cemia. Not even the 8 rabbits which had completed the whole course of 10 exposures developed any demonstrable agglutinins for Type II pneumococcus. 
Protective Antibodies
In Table II is shown the number of rabbits which were repeatedly sprayed from 1 to 10 times with Pneumococcus Type II (SAv) and the number thus exposed of which the serum subsequently protected mice against intraperitoneal injection of 0.001 co. of a virulent culture of Type II pneumococcus. From this table it is seen that protective antibodies were demonstrable in the sera of i of the rabbits after the 1st spray. Following each successive spraying, the percentage of rabbits showing protection steadily increased, until after the 8th spraying the serum of 90 per cent of the animals conferred passive protection on mice against at least 1000 lethal doses of virulent cultures. The development of protective antibodies is graphically shown in Text- fig. 1 . The exposure following which the rabbit sera first protected mice is shown in Table III . From this it is seen that with each successive spray the number of rabbits in the sera of which protective antibodies were demonstrable progressively increased. Certain rabbits showed protective antibodies only after the 7th or 8th exposure.
Pneumococcus II (Sv)
Of 50 rabbits sprayed from 1 to 10 times with the virulent strain of Type II (Sv) pneumococcus, 12 or 24 per cent died of pneumococcus septicemia after the first exposure. As the more susceptible animals succumbed early, serum was obtained only from rabbits with the greatest natural resistance, individuals which had also acquired a certain degree of immunity, as the result of repeated exposures to live pneumococci. In Table IV is shown the number of rabbits which were sprayed from 1 to 10 times whose serum showed agglutinins in dilutions of at least 1 to 10. From Table IV it is seen that 3 or 7 per cent of the 38 rabbits which survived the first exposure developed demonstrable agglutinins.
Only 4 rabbits developed agglutinins. In Table V are shown the exposures after which agglufinins first appeared and the titre of agglu-tinins following each subsequent spraying. Three rabbits showed agglutinins after the first exposure. Following the initial appearance of the agglufinins there is a tendency for the fitre to rise after subsequent exposures. But in one instance the agglutinins disappeared, and in another became less marked.
Protective A ntibodies
In Table VI are shown the number of rabbits that were sprayed from 1 to 10 times with rabbit virulent Pneumococcus II (Sv) and the num- seen that protective antibodies were demonstrable in the sera of 4 or 10 per cent of the rabbits after the 1st spray. Following each successive spraying the number of rabbits yielding serum which conferred passive protection increased, until after the 10th spraying the serum of 8 or 53 per cent of the animals conferred passive protection on mice against at least 1000 lethal doses of virulent culture. The spray following which the sera first protected mice is shown in Table VII .
From Table VII it is seen that after the 1st exposure the sera of 6 rabbits showed protective antibodies. After successive sprays an occasional rabbit would first show protective antibodies. Protective substances were first demonstrated in the sera of 3 rabbits only after the 10th exposure. 
Correlation of A gglutinins and Protective Antibodies
It is difficult to compare the relative titre of the sera at any one time because of the difference in the standards used. Whereas agglufinins were recorded as positive if present in serum concentration of 1 : 10, protective antibodies were noted only if they were present in concentrations sufficient to protect mice against a 0.001 cc. of virulent pneumococcus culture. If smaller doses of pneumococcus had been used, the presence of protective antibodies would undoubtedly have been detected earlier and the incidence of their occurrence would have been more frequent. However, when these antibodies were demonstrable under the conditions of this experiment, their presence was evidence of the capacity of the serum to confer a high degree of passive immunity on mice.
In 3 instances both agglutinins and protective antibodies occurred after the same spray; in another rabbit, yielding serum that contained agglutinins, protective antibodies appeared after the next exposure. In 9 instances protective antibodies occurred without demonstrable agglutinins in the serum and the sera of 7 rabbits, even after 10 exposures, contained no agglutinins or protective antibodies even sufficient to protect mice against 0.000,001 of a virulent Type II pneumococcus.
The relative occurrence of agglutinins and of protective antibodies in the serums of rabbits following inhalations of rabbit virulent strain of Type II (Sv) pneumococcus is graphically shown in Text- fig. 2 . In this figure the mortality curve of rabbits dying from pneumococcus septicemia is also given. It is seen that after the 1st exposure 24 per cent of the rabbits died from pneumococcus septicemia. An occasional rabbit died following subsequent exposures. The sera of the rabbits dying after the 3rd, 5th and 6th exposures showed neither agglutinins nor protective antibodies. The serum of the rabbit dying after the 10th spray, however, protected mice against 0.01 cc. of pneumococcus culture. It is unfortunate that it is not known if the pneumococcus recovered from this rabbit was the original type specific organism used for spraying or a degenerated "R" form. The number of rabbits that developed agglutinins was never great, nor was the titre high. The proportion of rabbits showing agglutinins rose only slightly following successive exposures. On the other hand, there was a distinct tendency for the proportion of rabbits to develop protective antibodies with each successive spray. Following the 10th exposure 53 per cent of the total number of survivals showed the presence of these immune substances in their serum.
DISCUSSION
Although too few rabbits were used to give as definite results as after spraying with Type I pneumococcus, some definite results are indicated. It appears that the immunological reactions of rabbits following inhalations of the same type of pneumococci vary in direct proportion to the virulence of the organism. In the case of exposure to a non-virulent degenerated "R" strain derived from Type II pneumococcus no type specific antibody response was elicited. If rabbits are allowed to inhale slightly virulent Type II (SAv) pneumococcus, none succumb to infection, although a certain number develop a pneumococcus septicemia. As the result of successive spraying a large proportion of the animals developed protective antibodies in their serum but no agglutinins. Following the initial exposure to a rabbitvirulent Pneumococcus Type II (Sv) the greatest number of rabbits succumbed to a fatal septicemia. Certain rabbits developed a high degree of immunity as evidenced by the presence of agglutinin and protective antibodies in their serum. Why a larger proportion of rabbits exposed to the slightly virulent Pneumococcus Type II (SAv) developed protective antibodies than those sprayed with the virulent Pneumococcus Type II (Sv) is difficult to explain. The reaction of the rabbits to inhalations of the virulent Type II (Sv) culture parallels the results obtained when rabbits were sprayed with a rabbit-virulent Type I pneumococcus.
From the foregoing experiments it is certain that following inhalation of living virulent pneumococci of Type I or II rabbits develop a high degree of immunity. This immunity is probably induced by a few organisms penetrating the respiratory epithelium and entering into the body tissues. It has already been shown that rabbits may recover from a transient pneumococcus septicemia following inhalation of pneumococci. The great variations both in the time of first appearance and in the final titre of ~mmune bodies are difficult to explain.
Among the factors which cannot be experimentally controlled are: first, the number of organisms which come to lodge within the respiratory tract following exposure to a bacterial spray; second, the number which are able to invade the tissues after implantation; and third, the final disposition of these bacteria in the animal body. In certain instances the multiplication of the invading organisms goes on unchecked until the death of the animal. In others a transient carrier state may occur with subsequent immunity responses. It is certainly significant that whereas the curve of incidence of protective antibodies steadily increases, the percentage of rabbits showing agg|utinins does not materially change after the 5th spraying. CONCLUSIONS 1. Following repeated inhalations of the degeneratcd non-virulent "R" forms of Type II pneumococcus, no type specific antibodies can be demonstrated in the serum of rabbits.
2. Following repeated inhalations of slightly virulent Type II (SAv) pneumococci, only protective antibodies can be demonstrated in the serum of rabbits.
3. Following repeated inhalations of virulent Type II (Sv) pneumococci, agglutinins and protective antibodies can be demonstrated in the serum of rabbits.
4. Following repeated exposures of rabbits to inhalation of pneumococci, the type specific response, evidenced by type specific protective antibodies and agglutinins, varies in direct proportion to the virulence of the culture used.
